Quantcast

2014 Opportunities in the US Endocrine Function Testing Market

April 8, 2014

LONDON, April 8, 2014 /PRNewswire/ — Reportbuyer.com has added a new market research report:

2014 Opportunities in the US Endocrine Function Testing Market



This new 271-page report from Venture Planning Group provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.

During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

“2014 Opportunities in the US Endocrine Function Testing Market” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Contains 271 pages and 18 tables


Introduction
Worldwide Market and Technology Overview
A. Major Endocrine Function Tests
1. Cortisol
2. Estradiol
3. Follicle-Stimulating Hormone (FSH)
4. Gastrin
5. Growth Hormone/IGF-1
6. Human Chorionic Gonadotropin (HCG)
7. LH
8. Progesterone
9. PTH/IO PTH
10. Prolactin
11. T3
12. T3 Free
13. T3 Uptake
14. T4 (Thyroxine)
15. T4 Free
16. TBG
17. Testosterone
18. Thyroglobulin Ab
19. TPO Ab
20. TSH
B. Instrumentation Review: Operating characteristics
and features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

D. Market Size, Growth and Major Supplier Shares
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments

- Abbott Laboratories
- AdnaGen
- Agilent Technologies
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- BioMerieux
- Bio-Rad
- DiaSorin
- Eiken
- Fujirebio/Innogenetics
- Instrumentation Laboratory
- Kyowa Medex
- Matritech/Alere
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Roche
- Siemens
- Sysmex
- Thermo Fisher
- Tosoh
- Wako
- Wallac/PE
List of Tables

Major Companies Developing or Marketing
FSH Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
LH Tests
Major Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
U.S.A., Endocrine Function Test Volume
Forecast By Market Segment
U.S.A., All Market Segments, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Test Volume Forecast by Assay
U.S.A., Endocrine Function Reagent Market
Forecast By Market Segment
U.S.A., All Market Segments, Endocrine
Function Reagent Market Forecast
by Assay
U.S.A., Hospital Laboratories, Endocrine
Function Reagent Market Forecast
by Assay
U.S.A., Commercial/Private Laboratories,
Endocrine Function Reagent Market
Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Endocrine Function Reagent Market
Forecast by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares


Read the full report:
2014 Opportunities in the US Endocrine Function Testing Market
http://www.reportbuyer.com/pharma_healthcare/diagnostics/2014_opportunities_us_endocrine_function_testing_market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus